1. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma
   Sirio Fiorino et al, 2016, World Journal of Gastroenterology CrossRef
2. MicroRNAs: Role in hepatitis C virus pathogenesis
   Shubham Shrivastava et al, 2015, Genes & Diseases CrossRef
3. Evaluating serum levels of miR-181a and miR-let7a in HCV infected Iranian patients compared with healthy individuals
   Shahrzad Moradifard et al, 2021, Gene Reports CrossRef
4. Let7b-5p is Upregulated in the Serum of Emirati Patients with Type 2 Diabetes and Regulates Insulin Secretion in INS-1 Cells
   Hayat Aljaibeji et al, 2022, Experimental and Clinical Endocrinology & Diabetes CrossRef
5. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients
   Noha Mousaad Elemam et al, 2021, International Journal of Molecular Sciences CrossRef
6. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma
   Qingbao Cheng et al, 2015, Scientific Reports CrossRef
7. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs
   Adit Singhal et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
8. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression
   Shuzhen Chang et al, 2017, BMC Cancer CrossRef
9. Micro-Players of Great Significance—Host microRNA Signature in Viral Infections in Humans and Animals
   Ewa Ostrycharz et al, 2022, International Journal of Molecular Sciences CrossRef
10. Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis
    Lili Wang et al, 2024, International Journal of General Medicine CrossRef